E-course: How to further evolve on personalized pharmacological treatment for BPE/LUTS?

The aim of this e-course is to provide updated evidence on personalized pharmacological treatment for BPH/LUTS.

Published Wed, 7 Dec 2022
Organiser European School of Urology (ESU)
CME 1.00
Duration Approx. 60 minutes

To achieve an in-depth knowledge on this topic the e-course will review the currently most robust treatment response predictors including newer developments such as bladder wall thickness or intravesical prostatic protrusion. The basis for an individualized treatment is a thorough diagnostic-work up and the recent developments with this respect will be reviewed. Finally, key evidence towards an individualized pharmacological BPH/LUTS treatment is presented.


  • Prof. Dr. S. Madersbacher (AT)
  • Assoc. Prof. M. Rieken (CH)
  • Prof. M. Oelke (DE)
  • Dr. P. Capogrosso (IT)


This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

Contact our organiser

European School of Urology (ESU)

Email:  educationonline@uroweb.org